Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: Clinical implications

Acta Ophthalmologica

Volumn 92, Issue 2, 2014, Pages 161-166

  Sullivan, Benjamin D ^a   Crews, Leslie A ^a   Messmer, Elisabeth M ^b   Foulks, Gary N ^c   Nichols, Kelly K ^d   Baenninger, Philipp ^e   Geerling, Gerd ^f   Figueiredo, Francisco ^e   Lemp, Michael A ^a,g,h  

^a TearLab Corporation   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d UNIVERSITY OF HOUSTON   (United States)

^e ROYAL VICTORIA INFIRMARY   (United Kingdom)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

correlation; dry eye disease; symptoms; tear osmolarity

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONJUNCTIVAL STAINING; CONTROLLED STUDY; CORNEAL STAINING; CORRELATION ANALYSIS; DRY EYE; EUROPE; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEIBOMIAN GRADING; MIDDLE AGED; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OCULAR SURFACE DISEASE INDEX; OSMOLARITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAINING; SYMPTOM ASSESSMENT; UNITED STATES; YOUNG ADULT;

CORRELATION; DRY EYE DISEASE; SYMPTOMS; TEAR OSMOLARITY;

ADULT; AGED; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DRY EYE SYNDROMES; EYELID DISEASES; FEMALE; HUMANS; MALE; MEIBOMIAN GLANDS; MIDDLE AGED; OSMOLAR CONCENTRATION; RETROSPECTIVE STUDIES; TEARS; YOUNG ADULT;

EID: 84896689287     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12012     Document Type: Article

References (39)

1. Begley CG, Chalmers RL, Abetz L, et al., (2003): The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci 44: 4753-4761.
2. Bell AJ, &, Sejnowski TJ, (1997): The "independent components" of natural scenes are edge filters. Vision Res 37: 3327-3338.
3. Brignole-Baudouin F, Baudouin C, Aragona P, et al., (2011): A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol 89: e591-e597.
4. Bron AJ, Yokoi N, Gafney E, &, Tiffany JM, (2009): Predicted phenotypes of dry eye: proposed consequences of its natural history. Ocul Surf 7: 78-92.
5. Craig JP, &, Tomlinson A, (1997): Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci 74: 8-13.
6. DEWS Report (2007): International Dry Eye WorkShop (2007). Ocul Surf 5: 65-204.
7. Di Pascuale MA, Espana EM, Kawakita T, &, Tseng SC, (2004): Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency. Br J Ophthalmol 88: 388-392.
8. Foulks GN, (2003): Challenges and pitfalls in clinical trials of treatments for dry eye. Ocul Surf 1: 20-30.
9. Foulks GN, &, Bron AJ, (2003): Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf 1: 107-126.
10. Fuentes-Paez G, Herreras JM, Cordero Y, Almaraz A, Gonzalez MJ, &, Calonge M, (2011): Lack of concordance between dry eye syndrome questionnaires and diagnostic tests. Arch Soc Esp Oftalmol 86: 3-7.
11. Gilbard JP, &, Rossi SR, (1994): Changes in tear ion concentrations in dry-eye disorders. Adv Exp Med Biol 350: 529-533.
12. Gleghorn JP, Jones AR, Flannery CR, &, Bonassar LJ, (2007): Boundary mode frictional properties of engineered cartilaginous tissues. Eur Cell Mater 14: 20-28; discussion 28-29.
13. Hara S, Kojima T, Ishida R, et al., (2011): Evaluation of tear stability after surgery for conjunctivochalasis. Optom Vis Sci 88: 1112-1118.
14. Johnson ME, &, Murphy PJ, (2005): The Effect of instilled fluorescein solution volume on the values and repeatability of TBUT measurements. Cornea 24: 811-817.
15. Kallarackal GU, Ansari EA, Amos N, Martin JC, Lane C, &, Camilleri JP, (2002): A comparative study to assess the clinical use of Fluorescein Meniscus Time (FMT) with Tear Break up Time (TBUT) and Schirmer's tests (ST) in the diagnosis of dry eyes. Eye (Lond) 16: 594-600.
16. Korb DR, (2000): Survey of preferred tests for diagnosis of the tear film and dry eye. Cornea 19: 483-486.
17. Larmo PS, Jarvinen RL, Setala NL, Yang B, Viitanen MH, Engblom JR, Tahvonen RL, &, Kallio HP, (2010): Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye. J Nutr 140: 1462-1468.
18. Lemp MA, (1995): Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J 21: 221-232.
19. Lemp MA, &, Hamill JR Jr, (1973): Factors affecting tear film break-up in normal eyes. Arch Ophthalmol 89: 103-105.
20. Lemp MA, Bron AJ, Baudouin C, et al., (2011): Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 151: 792-798 e791.
21. Lemp MA, Crews LA, Bron AJ, Foulks GN, &, Sullivan BD, (2012): Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea 31: 472-478.
22. Liu H, Begley C, Chen M, Bradley A, Bonanno J, McNamara NA, Nelson JD, &, Simpson T, (2009): A link between tear instability and hyperosmolarity in dry eye. Invest Ophthalmol Vis Sci 50: 3671-3679.
23. Luo L, Li DQ, Corrales RM, &, Pflugfelder SC, (2005): Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens 31: 186-193.
24. Luo L, Li DQ, &, Pflugfelder SC, (2007): Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways. Cornea 26: 452-460.
25. Messmer EM, Bulgen M, &, Kampik A, (2010): Hyperosmolarity of the tear film in dry eye syndrome. Dev Ophthalmol 45: 129-138.
26. Miller KL, Walt JG, Mink DR, Satram-Hoang S, Wilson SE, Perry HD, Asbell PA, &, Pflugfelder SC, (2010): Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 128: 94-101.
27. Mizuno Y, Yamada M, &, Miyake Y, (2010): Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome. Jpn J Ophthalmol 54: 259-265.
28. Moore JE, Graham JE, Goodall EA, Dartt DA, Leccisotti A, McGilligan VE, &, Moore TC, (2009): Concordance between common dry eye diagnostic tests. Br J Ophthalmol 93: 66-72.
29. Nelson JD, &, Farris RL, (1988): Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca. Arch Ophthalmol 106: 484-487.
30. Nichols KK, Nichols JJ, &, Mitchell GL, (2004): The lack of association between signs and symptoms in patients with dry eye disease. Cornea 23: 762-770.
31. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, &, Reis BL, (2000): Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118: 615-621.
32. Sullivan BD, Whitmer D, Nichols KK, et al., (2010): An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 51: 6125-6130.
33. Sullivan BD, Crews LA, Sonmez B, et al., (2012): Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials. Cornea 31: 1000-1008.
34. Versura P, Profazio V, &, Campos EC, (2010): Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Curr Eye Res 35: 553-564.
35. Viso E, Rodriguez-Ares MT, Abelenda D, Oubina B, &, Gude F, (2012): Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci 53: 2601-2606.
36. Watanabe A, Yokoi N, Kinoshita S, Hino Y, &, Tsuchihashi Y, (2004): Clinicopathologic study of conjunctivochalasis. Cornea 23: 294-298.
37. Wojtowicz JC, Butovich I, Uchiyama E, Aronowicz J, Agee S, &, McCulley JP, (2011): Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea 30: 308-314.
38. Yang Y, Abrams M, Garner W, et al., (2012): An exploration of the relationships between tear osmolarity and other measures of dry eye signs and symptoms. Invest Ophthalmol Vis Sci 53: ARVO e-Abstract 548.
39. Yokoi N, Komuro A, Nishii M, Inagaki K, Tanioka H, Kawasaki S, &, Kinoshita S, (2005): Clinical impact of conjunctivochalasis on the ocular surface. Cornea 24: S24-S31.